De novo pathogenic CSF1R variant implicates microglial dysfunction in pathogenesis of febrile infection‐related epilepsy syndrome
Epilepsia · 2025-09 · 66 (9)
DOI: 10.1111/epi.18538 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epilepsia, online erschienen am 05.07.2025. Verfasst von Kristen S Fisher und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Te…. Hauptthemen laut MEDLINE: Microglia, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Drug Resistant Epilepsy, Seizures, Febrile. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Febrile infection‐related epilepsy syndrome (FIRES) is a rare presentation of refractory status epilepticus following a febrile illness with resulting refractory epilepsy. Evidence supports the presence of immune dysregulation in patients with FIRES, but a monogenic basis for FIRES has not been identified in most cases. We present a case of a previously healthy 16‐year‐old male with FIRES who was found to have a de novo predicted damaging missense variant in CSF1R on clinical whole genome sequencing, a gene encoding a critical regulator of microglial homeostasis in which pathogenic variants cause adult onset leukoencephalopathy. Molecular modeling demonstrates that the CSF1R variant likely destabilizes the critical ATP‐binding domain of the CSF1 receptor. Furthermore, the variant was shown to disrupt CSF1R autophosphorylation in response to CSF1 treatment, thereby establishing its pathogenicity. This case proposes a role of microglial dysfunction in the pathogenesis of FIRES, contributing to the existing literature proposing innate immune dysregulation as an etiology of FIRES. These findings may suggest consideration of interventions targeting microglia specifically in the treatment of patients with FIRES.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- Division of Pediatric Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine at Texas Children's Hospital, Houston, Texas, USA.
- Division of Rheumatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
- Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
- iEEG and Animal Biotechnology Research Center, National Chung Hsing University, Taichung, Taiwan.
ORCID-Profile: Kristen S Fisher, Jesse M Levine, Alexander Ankar, Ruizhi Duan, Yi Chen Lai, Eyal Muscal, Sarah R Risen, Pei-Chien Tsai, Daniel G Calame
Förderung
- NINDS NIH HHS
Zitieren
APA
Fisher, K. S., Levine, J. M., Ankar, A., Duan, R., Lai, Y. C., Muscal, E., Risen, S. R., Riviello, J. J., Tsai, P. C., & Calame, D. G. (2025). De novo pathogenic CSF1R variant implicates microglial dysfunction in pathogenesis of febrile infection‐related epilepsy syndrome. Epilepsia, 66(9). https://doi.org/10.1111/epi.18538
Vancouver
Fisher KS, Levine JM, Ankar A, Duan R, Lai YC, Muscal E, et al. De novo pathogenic CSF1R variant implicates microglial dysfunction in pathogenesis of febrile infection‐related epilepsy syndrome. Epilepsia. 2025;66(9). doi:10.1111/epi.18538
BibTeX
@article{Fisher2025,
author = {Fisher, Kristen S and Levine, Jesse M and Ankar, Alexander and Duan, Ruizhi and Lai, Yi Chen and Muscal, Eyal and Risen, Sarah R and Riviello, James J and Tsai, Pei-Chien and Calame, Daniel G},
title = {De novo pathogenic CSF1R variant implicates microglial dysfunction in pathogenesis of febrile infection‐related epilepsy syndrome},
journal = {Epilepsia},
year = {2025},
volume = {66},
number = {9},
doi = {10.1111/epi.18538}
}
EUVIMED